Circulation Research, Vol 74, 105-114, Copyright © 1994 by American Heart Association

ARTICLES

Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries

JR Teerlink, V Breu, U Sprecher, M Clozel and JP Clozel
Pharma Division, F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Endothelin (ET) 1 is a powerful vasoconstrictor of coronary arteries and may play a role in coronary spasm, atherosclerosis, and myocardial infarction. Previous studies have demonstrated that intracoronary ET caused marked vasoconstriction of the coronary circulation; however, it remains unclear which ET receptor types are present and which of these receptors mediate this vasoconstriction. To characterize the ET receptors present in dog coronary arteries, competition binding assays with radiolabeled ET-1 using ET-1, ET-3, ETA receptor antagonist BQ- 123, and sarafotoxin S6c were performed. Three binding sites were apparent in the left circumflex coronary artery: an ETA receptor, a high-affinity ETB receptor, and a lower-affinity ETB receptor. To investigate the in vivo effects of ETB receptor stimulation, intracoronary sarafotoxin S6c, a highly selective ETB agonist, was administered in anesthetized open-chest dogs in a constant-pressure coronary artery perfusion model. Sarafotoxin S6c doses of 0.1 and 0.3 microgram caused a transient pronounced decrease in coronary resistance. Doses of 1.0 and 3.0 micrograms caused marked decreases in coronary diameter and blood flow, as well as myocardial segmental shortening. These effects of sarafotoxin S6c were not inhibited by constant infusion of BQ-123. The present study demonstrates the presence of ETB receptors in the canine coronary circulation that can mediate both vasodilation and vasoconstriction. These findings have important implications for an understanding of the pathophysiological function of ET in the coronary vasculature and for the development of therapeutically effective ET antagonists.

This article has been cited by other articles:

				N. R. Tykocki, C. E. Gariepy, and S. W. Watts Endothelin ETB Receptors in Arteries and Veins: Multiple Actions in the Vein J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 875 - 881. [Abstract] [Full Text] [PDF]

				R. M. Fryer, P. A. Rakestraw, P. N. Banfor, B. F. Cox, T. J. Opgenorth, and G. A. Reinhart Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2554 - H2559. [Abstract] [Full Text] [PDF]

				D. Konrad, A. Oldner, M. Wanecek, A. Rudehill, E. Weitzberg, B. Biber, G. Johansson, S. Haggmark, and M. Haney Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1702 - H1709. [Abstract] [Full Text] [PDF]

				H. F. Galley and N. R. Webster Physiology of the endothelium Br. J. Anaesth., July 1, 2004; 93(1): 105 - 113. [Abstract] [Full Text] [PDF]

				D. Merkus, B. Houweling, A. Mirza, F. Boomsma, A. H van den Meiracker, and D. J Duncker Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation Cardiovasc Res, September 1, 2003; 59(3): 745 - 754. [Abstract] [Full Text] [PDF]

				L. Miao, Y. Dai, and J. Zhang Mechanism of RhoA/Rho kinase activation in endothelin-1- induced contraction in rabbit basilar artery Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H983 - H989. [Abstract] [Full Text] [PDF]

				K. Tadano, J. Suzuki, K. Hanada, M. Nakao, R. Nakao, S. Uehara, H. Ohta, T. Miyauchi, and M. Nishikibe Pathophysiological Roles of Endogenous Endothelin-1 in Dogs with Chronic Heart Failure Produced by Rapid Right Ventricular Pacing J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 729 - 736. [Abstract] [Full Text] [PDF]

				D. Evans and P. Piermarini Contractile properties of the elasmobranch rectal gland J. Exp. Biol., January 1, 2001; 204(1): 59 - 67. [Abstract] [PDF]

				C. S. Louden, P. Nambi, M. A. Pullen, R. A. Thomas, L. A. Tierney, H. A. Solleveld, and L. W. Schwartz Endothelin Receptor Subtype Distribution Predisposes Coronary Arteries to Damage Am. J. Pathol., July 1, 2000; 157(1): 123 - 134. [Abstract] [Full Text] [PDF]

				R. Parent and M. Lavallee Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs Cardiovasc Res, January 14, 2000; 45(2): 470 - 477. [Abstract] [Full Text] [PDF]

				K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama Contribution of Endothelin-1 to Myocardial Injury in a Murine Model of Myocarditis : Acute Effects of Bosentan, an Endothelin Receptor Antagonist Circulation, October 26, 1999; 100(17): 1823 - 1829. [Abstract] [Full Text] [PDF]

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				E. Thorin, R. Parent, Z. Ming, and M. Lavallee Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H524 - H532. [Abstract] [Full Text] [PDF]

				A. T Goodwin, M. Amrani, A. J Marchbank, C. C Gray, J. Jayakumar, and M. H Yacoub Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion Cardiovasc Res, March 1, 1999; 41(3): 554 - 562. [Abstract] [Full Text] [PDF]

				J. E. Lipa, P. C. Neligan, T. M. Perreault, J. Baribeau, R. H. Levine, R. J. Knowlton, and C. Y. Pang Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H359 - H367. [Abstract] [Full Text] [PDF]

				D. Evans and M. Gunderson Characterization of an endothelin ET(B) receptor in the gill of the dogfish shark Squalus acanthias J. Exp. Biol., January 12, 1999; 202(24): 3605 - 3610. [Abstract] [PDF]

				M. E. Beyer, G. Slesak, T. Hovelborn, S. Kazmaier, S. Nerz, and H. M. Hoffmeister Inotropic Effects of Endothelin-1 : Interaction With Molsidomine and With BQ 610 Hypertension, January 1, 1999; 33(1): 145 - 152. [Abstract] [Full Text] [PDF]

				K. Alexiou, T. Dschietzig, O. Simsch, M. Laule, J. Hundertmark, G. Baumann, and K. Stangl Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin: Aggravation of this phenomenon in heritable hyperlipidemia J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1773 - 1778. [Abstract] [Full Text] [PDF]

				Z. Ming, R. Parent, E. Thorin, and M. Lavallee Endothelin-Dependent Tone Limits Acetylcholine-Induced Dilation of Resistance Coronary Vessels After Blockade of NO Formation in Conscious Dogs Hypertension, November 1, 1998; 32(5): 844 - 848. [Abstract] [Full Text] [PDF]

				R. Choussat, L. Hittinger, F. Barbe, G. Maistre, A. Carayon, B. Crozatier, and J. Su Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs Cardiovasc Res, September 1, 1998; 39(3): 580 - 588. [Abstract] [Full Text] [PDF]

				G. P. Rossi, E. Zilli, A. C. Pessina, K. A.H. Kaasjager, H. A. Koomans, and T. J. Rabelink Renal Effects of Endothelin-1 in Essential Hypertension • Response Hypertension, February 1, 1998; 31(2): 721 - 722. [Full Text]

				D. Hasdai, P. J.M. Best, C. R. Cannan, V. Mathew, R. S. Schwartz, D. R. Holmes Jr, and A. Lerman Acute Endothelin-Receptor Inhibition Does Not Attenuate Acetylcholine-Induced Coronary Vasoconstriction in Experimental Hypercholesterolemia Arterioscler Thromb Vasc Biol, January 1, 1998; 18(1): 108 - 113. [Abstract] [Full Text] [PDF]

				D. Hasdai, V. Mathew, R. S. Schwartz, L. A. Smith, D. R. Holmes Jr, Z. S. Katusic, and A. Lerman Enhanced Endothelin-B-Receptor–Mediated Vasoconstriction of Small Porcine Coronary Arteries in Diet-Induced Hypercholesterolemia Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2737 - 2743. [Abstract] [Full Text]

				F. Cartier, I. Remy-Jouet, A. Fournier, H. Vaudry, and C. Delarue Effect of Endothelin-1 on Corticosteroid Secretion by the Frog Adrenal Gland Is Mediated by an EndothelinA Receptor Endocrinology, October 1, 1997; 138(10): 4358 - 4363. [Abstract] [Full Text] [PDF]

				G. Matsuo, Y. Matsumura, K. Tadano, and S. Morimoto Effects of Sarafotoxin S6c on Antidiuresis and Norepinephrine Overflow Induced by Stimulation of Renal Nerves in Anesthetized Dogs J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 905 - 910. [Abstract] [Full Text]

				H. Shimoyama, H. N. Sabbah, S. Borzak, M. Tanimura, S. Shevlyagin, G. Scicli, and S. Goldstein Short-term Hemodynamic Effects of Endothelin Receptor Blockade in Dogs With Chronic Heart Failure Circulation, August 15, 1996; 94(4): 779 - 784. [Abstract] [Full Text]

				C. R. Cannan, J. C. Burnett Jr, R. R. Brandt, and A. Lerman Endothelin at Pathophysiological Concentrations Mediates Coronary Vasoconstriction via the Endothelin-A Receptor Circulation, December 1, 1995; 92(11): 3312 - 3317. [Abstract] [Full Text]

				E. L. Schiffrin Endothelin: Potential Role in Hypertension and Vascular Hypertrophy Hypertension, June 1, 1995; 25(6): 1135 - 1143. [Abstract] [Full Text]